Ge Healthcare Technologies Inc. GEHC

Revenue Intelligence Report • 17 quarters of SEC filing data • Updated 2026-10-14 • Data through 2026-03-31

Ge Healthcare Technologies Inc.'s latest quarterly revenue is $5.1B for the period ending 2026-03-31. The model projects $21.3B across the next four quarters (+1.7% versus the preceding four quarters). The forecast uses SG&A data; model selection and estimation exclude the latest quarter, whose retrospective holdout error is 9.3%. These are statistical associations, not estimates of the causal effect of spending.

Investment Thesis

The GAM forecast is based on reported revenue and SG&A data through 2026-03-31. Training MAPE measures fit to historical data; the separately reported holdout error measures a withheld quarter. Spending coefficients describe associations and do not establish causation.

Next 4 Quarters
$21.3B
+1.7% YoY
R&D Multiplier
$478385770640.53 per $1
SG&A Multiplier
$64167544204.87 per $1
Training Fit
1.7% MAPE
Retrospective holdout (Q1 FY2026): The model predicted $4.66B vs the actual $5.13B — an error of 9.3%.
Retrospective one-quarter holdout: model fitting and selection exclude this quarter. Historical inputs use the latest available restatements, so this is not a preserved real-time forecast.

Revenue Forecast

GEHC Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q1 FY2026
Period end 2026-03-31		 $4.66B $5.13B $4.29B–$5.06B -2.5% ✗ Outside range
Q2 FY2026
Period end 2026-06-30		 $5.11B $4.72B–$5.53B +2.1%
Q3 FY2026
Period end 2026-09-30		 $5.56B $5.09B–$6.07B +8.1%
Q4 FY2026
Period end 2026-12-31		 $6.01B $5.54B–$6.52B +5.5%
Q1 FY2027
Period end 2027-03-31		 $4.66B $4.22B–$5.14B -9.2%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Ge Healthcare Technologies Inc.'s systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Jan–Mar) 1.0063 +0.6% In line with trend 4
FQ2 (Apr–Jun) 0.9889 -1.1% In line with trend 4
FQ3 (Jul–Sep) 0.9943 -0.6% In line with trend 4
FQ4 (Oct–Dec) 1.0133 +1.3% In line with trend 4

Spending and Revenue

GEHC Spending Timing
Reading this chart: Each line shows the cumulative revenue association per $1 of spending over subsequent quarters. These estimates describe historical associations and do not establish causation.

Time-Varying Spending Associations

Time-varying analysis: A penalized spline model (GAM) tracks the association between log spending and log revenue over 17 quarters. Its coefficients describe conditional historical associations, not causal returns on spending.
Current SG&A elasticity: 2.3574x • R&D elasticity: -0.8595x
The model-term chart shows relative absolute term magnitudes. Its percentages are not shares of revenue or causal contributions to growth.
Enhanced forecast: The time-varying model (GAM) was selected using training fit, before evaluating the withheld quarter. Its holdout error is -9.3%.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

Data sourced from SEC EDGAR XBRL filings. SEC source data. Forecast model: GAM; spending associations: ARDL (linear) with 17 quarters. This analysis is for informational purposes only and does not constitute investment advice.

More in Healthcare

DXCM TECH IDXX A BSX ABBV CAH TMO